In biology, an atavism is a modification of a biological structure whereby an ancestral genetic trait reappears after having been lost through evolutionary change in previous generations. Atavisms can occur in several ways, one of which is when genes for previously existing phenotypic features are preserved in DNA, and these become expressed through a mutation that either knocks out the dominant genes for the new traits or makes the old traits dominate the new one. A number of traits can vary as a result of shortening of the fetal development of a trait (neoteny) or by prolongation of the same. In such a case, a shift in the time a trait is allowed to develop before it is fixed can bring forth an ancestral phenotype. Atavisms are often seen as evidence of evolution.In social sciences, atavism is the tendency of reversion. For example, people in the modern era reverting to the ways of thinking and acting of a former time.
The word atavism is derived from the Latin atavus—a great-great-great-grandfather or, more generally, an ancestor.

Biology
Evolutionarily traits that have disappeared phenotypically do not necessarily disappear from an organism's DNA. The gene sequence often remains, but is inactive. Such an unused gene may remain in the genome for many generations. As long as the gene remains intact, a fault in the genetic control suppressing the gene can lead to it being expressed again. Sometimes, the expression of dormant genes can be induced by artificial stimulation.
Atavisms have been observed in humans, such as with infants born with vestigial tails (called a "coccygeal process", "coccygeal projection", or "caudal appendage"). Atavism can also be seen in humans who possess large teeth, like those of other primates. In addition, a case of "snake heart", the presence of "coronary circulation and myocardial architecture [that closely] resemble those of the reptilian heart", has also been reported in medical literature. Atavism has also recently been induced in avian dinosaur (bird) fetuses to express dormant ancestral non-avian dinosaur (non-bird) features, including teeth.Other examples of observed atavisms include:

Hind limbs in cetaceans and sirenians.
Extra toes of the modern horse.
Reappearance of limbs in limbless vertebrates.
Re-evolution of sexuality from parthenogenesis in oribatid mites.
Teeth in avian dinosaurs (birds).
Dewclaws in dogs.
Reappearance of prothoracic wings in insects.
Reappearance of wings on wingless stick insects and leaf insects and earwigs.
Atavistic muscles in several birds and mammals such as the beagle and the jerboa.
Extra toes in guinea pigs.
Reemergence of sexual reproduction in the flowering plant Hieracium pilosella and the Crotoniidae family of mites.
Webbed feet in adult axolotls.
Human tails (not pseudo-tails) and supernumerary nipples in humans (and other primates).
Color blindness in humans.

Culture
Atavism is a term in Joseph Schumpeter's explanation of World War I in twentieth-century liberal Europe. He defends the liberal international relations theory that an international society built on commerce will avoid war because of war's destructiveness and comparative cost. His reason for World War I is termed "atavism", in which he asserts that senescent governments in Europe (those of the German Empire, Russian Empire, Ottoman Empire, and Austro-Hungarian Empire) pulled the liberal Europe into war, and that the liberal regimes of the other continental powers did not cause it. He used this idea to say that liberalism and commerce would continue to have a soothing effect in international relations, and that war would not arise between nations which are connected by commercial ties. This latter idea is very similar to the later Golden Arches theory.
University of London professor Guy Standing has identified three distinct sub-groups of the precariat, one of which he refers to as "atavists", who long for what they see as a lost past.

Social Darwinism
During the interval between the acceptance of evolution in the mid-1800s and the rise of the modern understanding of genetics in the early 1900s, atavism was used to account for the reappearance in an individual of a trait after several generations of absence—often called a "throw-back". The idea that atavisms could be made to accumulate by selective breeding, or breeding back, led to breeds such as Heck cattle. This had been bred from ancient landraces with selected primitive traits, in an attempt of "reviving" the aurochs, an extinct species of wild cattle. The same notions of atavisms were used by social Darwinists, who claimed that "inferior" races displayed atavistic traits, and represented more primitive traits than other races. Both atavism's and Ernst Haeckel's recapitulation theory are related to evolutionary progress, as development towards a greater complexity and a superior ability.In addition, the concept of atavism as part of an individualistic explanation of the causes of criminal deviance was popularised by the Italian criminologist Cesare Lombroso in the 1870s. He attempted to identify physical characteristics common to criminals and labeled those he found as atavistic, 'throw-back' traits that determined 'primitive' criminal behavior. His statistical evidence and the closely related idea of eugenics have long since been abandoned by the scientific community, but the concept that physical traits may affect the likelihood of criminal or unethical behavior in a person still has some scientific support.

See also
Atavistic regression
Exaptation
Spandrel (biology)
Torna atrás

References
External links

Bar-Maor, JA; Kesner, KM; Kaftori, JK (November 1980). "Human tails". The Journal of Bone and Joint Surgery. British Volume. 62-B (4): 508–510. doi:10.1302/0301-620x.62b4.7430236. PMID 7430236.
Photograph of an additional (third) hoof of cows


Autogamy depression can be defined as the "lowered viability of autogamous progeny relative to geitonogamous progeny". Viability has also been evaluated in terms of percent fruit set or  seed set rather than reproductive fitness of the progeny. The experimental design for observing the occurrence of autogamy depression is called an "autogamy depression test" which has been described by researchers as analogous to a test for inbreeding depression. The ability for fitness of autogamous progeny to differ from geitonogamous progeny comes from the understanding that plants can accumulate heritable mutational variation through both mitotic division and meiotic division. Because plants have indeterminate growth, the apical meristems that contribute to the development of the reproductive structures of a plant have the potential to undergo continual mitosis resulting in the accumulation of somatic mutations (acquired mutations). It has been demonstrated through research that long lived plants can have higher per generation mutation rate (based on occurrences of more mitotic cell divisions compared to short lived plants). Any deleterious mutations that appear during mitotic growth are filtered out through cell lineage selection, in which deleterious mutations that are subject to developmental selection during mitotic growth are replaced by vigorous cell lineages, however, somatic mutations that are not expressed will not be subject to selection during growth of the plant and will accumulate in the apical meristem.

Phenotypic effects of somatic mutations
There is evidence of the phenotypic effects of somatic mutations in increased chlorophyll mutants of some long-lived plants. Chlorophyll mutants are inherently easy to observe because of the phenotypic effects of the chlorophyll mutations. Because of the highly conserved nature of photosynthetic processes, these chlorophyll mutation rates can be generalized to most angiosperms. Somatic mutations accumulating during vegetative growth have also been found to affect the fitness of seedlings in the next generation.

Expectations of autogamy depression test
Individual crowns are treated as "independent mitotic mutation-accumulation lines" and so the appearance of deleterious somatic mutations in the autogamous crosses will be heterozygous or homozygous at the same locus (~25% homozygous) and the appearance of deleterious somatic mutations in the geitonogamous crosses will be heterozygous. The autogamy depression can be calculated through the simple equation AD = 1 − (wa/wg), where AD is the autogamy depression, wa is the fitness of the autogamous progeny and wg is the fitness of the geitonogamous progeny. When the fitnesses are equal the AD is 0. The difference can be calculated by the equation D = wg − wa.

== References ==


Backcrossing is a crossing of a hybrid with one of its parents or an individual genetically similar to its parent, to achieve offspring with a genetic identity closer to that of the parent. It is used in horticulture, animal breeding, and  production of gene knockout organisms.
Backcrossed hybrids are sometimes described with acronym "BC"; for example, an F1 hybrid crossed with one of its parents (or a genetically similar individual) can be termed a BC1 hybrid, and a further cross of the BC1 hybrid to the same parent (or a genetically similar individual) produces a BC2 hybrid.

Plants
Advantages
If the recurrent parent is an elite genotype, at the end of the backcrossing programme, an elite genotype is recovered.
As no "new" recombination results, the elite combination is not lost.

Disadvantages
It works poorly for quantitative traits.
It is more restricted for recessive traits.
In practice, sections of genome from the nonrecurrent parents are often still present and can have unwanted traits associated with them.
For very wide crosses, limited recombination may maintain thousands of "alien" genes within the elite cultivar.
Many backcrosses are required to produce a new cultivar, which can take many years.

Natural backcrossings
York radiate groundsel (Senecio eboracensis) is a naturally occurring hybrid species of Oxford ragwort (Senecio squalidus) and common groundsel (Senecio vulgaris). It is thought to have arisen from a backcrossing of the F1 hybrid with S. vulgaris.Again, the pure tall (TT) and pure dwarf (tt) pea plants when crossed in the parental generation, produce all heterozygote (Tt) tall pea plants in the first filial generation. The cross between first filial heterozygote tall (Tt) pea plant and pure tall (TT) or pure dwarf (tt) pea plant of the parental generation is also an example for the back-crossing between two plants. In this case, the filial generation formed after the back cross may have a phenotype ratio of 1:1 if the cross is made with recessive parent or else all offspring may be having phenotype of dominant trait if the backcross is with a parent having the dominant trait. The former of these traits is also called a test cross.

Artificially recombinant lines
In plants, the term inbred backcross line (IBL) refers to a line (i.e. population) of plants derived from the repeated backcrossing of a line with artificially recombinant DNA with the wild type, operating some kind of selection that can be phenotypical or through a molecular marker (for the production of an introgression line).

Animals
Backcrossing may be deliberately employed in animals to transfer a desirable trait in an animal of inferior genetic background to an animal of preferable genetic background. In gene-knockout experiments in particular, where the knockout is performed on easily cultured stem cell lines, but is required in an animal with a different genetic background, the knockout animal is backcrossed against the animal of the required genetic background. As the figure shows, each time that the mouse with the desired trait (in this case the lack of a gene (i.e. a knockout), indicated by the presence of a positive selectable marker) is crossed with a mouse of a constant genetic background, the average percentage of the genetic material of the offspring that is derived from that constant background increases. The result, after sufficient reiterations, is an animal with the desired trait in the desired genetic background, with the percentage of genetic material from the original stem cells reduced to a minimum (on the order of 0.01%).Due to the nature of meiosis, in which chromosomes derived from each parent are randomly shuffled and assigned to each nascent gamete, the percentage of genetic material deriving from either cell line varies between offspring of a single crossing, but will have an expected value. The genotype of each member of offspring may be assessed to choose not only an individual that carries the desired genetic trait, but also the minimum percentage of genetic material from the original stem cell line.
A consomic strain is an inbred strain with one of its chromosomes replaced by the homologous chromosome of another inbred strain via a series of marker-assisted backcrosses.

See also
Introgression
Incest

References
External links
The Plant Breeding and Genomics Community of Practice on eXtension - education and training materials for plant breeders and allied professionals


A Barr body (named after discoverer Murray Barr) or X-chromatin is an inactive X chromosome.  In species with  XY sex-determination (including humans), females typically have two X chromosomes, and one is rendered inactive in a process called lyonization. Errors in chromosome separation can also result in male and female individuals with extra X chromosomes.  The Lyon hypothesis states that in cells with multiple X chromosomes, all but one are inactivated early in embryonic development  in mammals. The  X chromosomes that become inactivated are chosen randomly, except in marsupials and in some extra-embryonic tissues of some placental mammals, in which the X chromosome from the sperm is always deactivated.In humans with euploidy, a genotypical female (46, XX karyotype) has one Barr body per somatic cell nucleus, while a genotypical male (46, XY) has none. The Barr body can be seen in the interphase nucleus as a darkly staining small mass in contact with the nucleus membrane. Barr bodies can be seen in neutrophils at the rim of the nucleus.
In humans with more than one X chromosome, the number of Barr bodies visible at interphase is always one fewer than the total number of X chromosomes. For example, people with Klinefelter syndrome (47, XXY) have a single Barr body, and people with a 47, XXX karyotype have two Barr bodies.

Mechanism
Someone with two X chromosomes (such as most human females) has only one Barr body per somatic cell, while someone with one X chromosome (such as most human males) has none.
Mammalian X-chromosome inactivation is initiated from the X inactivation centre or Xic, usually found near the centromere. The center contains twelve genes, seven of which code for proteins, five for untranslated RNAs, of which only two are known to play an active role in the X inactivation process, Xist and Tsix. The centre also appears to be important in chromosome counting: ensuring that random inactivation only takes place when two or more X-chromosomes are present. The provision of an extra artificial Xic in early embryogenesis can induce inactivation of the single X found in male cells.The roles of Xist and Tsix appear to be antagonistic. The loss of Tsix expression on the future inactive X chromosome results in an increase in levels of Xist around the Xic. Meanwhile, on the future active X Tsix levels are maintained; thus the levels of Xist remain low. This shift allows Xist to begin coating the future inactive chromosome, spreading out from the Xic. In non-random inactivation this choice appears to be fixed and current evidence suggests that the maternally inherited gene may be imprinted. Variations in Xi frequency have been reported with age, pregnancy, the use of oral contraceptives, fluctuations in menstrual cycle and neoplasia.It is thought that this constitutes the mechanism of choice, and allows downstream processes to establish the compact state of the Barr body. These changes include histone modifications, such as histone H3 methylation (i.e. H3K27me3 by PRC2 which is recruited by Xist) and histone H2A ubiquitination, as well as direct modification of the DNA itself, via the methylation of CpG sites. These changes help inactivate gene expression on the inactive X-chromosome and to bring about its compaction to form the Barr body.
Reactivation of a Barr body is also possible, and has been seen in breast cancer patients. One study showed that the frequency of Barr bodies in breast carcinoma were significantly lower than in healthy controls, indicating reactivation of these once inactivated X chromosomes.

See also
X-inactivation
Sex-determination system
Nuclear sexing, a genetic sex determination technique
Demethylation
Acetylation
Xist
Tsix (gene)

References
Links to full text articles are provided where access is free, in other cases only the abstract has been linked.

Further reading
Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. (2002). Molecular Biology of the Cell, Fourth Edition. Garland Science. pp. 428–429. ISBN 978-0-8153-4072-0. (Web Edition, Free access)
Turnpenny & Ellard: Emery's Elements of Medical Genetics 13E (http://www.studentconsult.com/content/default.cfm?ISBN=9780702029172&ID=HC006029 Archived 2020-04-13 at the Wayback Machine)


A blood type (also known as a blood group) is  a classification of blood, based on the presence and absence of antibodies and inherited antigenic substances on the surface of red blood cells (RBCs). These antigens may be proteins, carbohydrates, glycoproteins, or glycolipids, depending on the blood group system. Some of these antigens are also present on the surface of other types of cells of various tissues. Several of these red blood cell surface antigens can stem from one allele (or an alternative version of a gene) and collectively form a blood group system.Blood types are inherited and represent contributions from both parents of an individual. As of December 2023, a total of 45 human blood group systems are recognized by the International Society of Blood Transfusion (ISBT). The two most important blood group systems are ABO and Rh; they determine someone's blood type (A, B, AB, and O, with + or − denoting RhD status) for suitability in blood transfusion.

Blood group systems
A complete blood type would describe each of the 45 blood groups, and an individual's blood type is one of many possible combinations of blood-group antigens. Almost always, an individual has the same blood group for life, but very rarely an individual's blood type changes through addition or suppression of an antigen in infection, malignancy, or autoimmune disease. Another more common cause of blood type change is a bone marrow transplant. Bone-marrow transplants are performed for many leukemias and lymphomas, among other diseases. If a person receives bone marrow from someone of a different ABO type (e.g., a type O patient receives a type A bone marrow), the patient's blood type should eventually become the donor's type, as the patient's hematopoietic stem cells (HSCs) are destroyed, either by ablation of the bone marrow or by the donor's T-cells. Once all the patient's original red blood cells have died, they will have been fully replaced by new cells derived from the donor HSCs. Provided the donor had a different ABO type, the new cells' surface antigens will be different from those on the surface of the patient's original red blood cells.Some blood types are associated with inheritance of other diseases; for example, the Kell antigen is sometimes associated with McLeod syndrome. Certain blood types may affect susceptibility to infections, an example being the resistance to specific malaria species seen in individuals lacking the Duffy antigen. The Duffy antigen, presumably as a result of natural selection, is less common in population groups from areas having a high incidence of malaria.

ABO blood group system
The ABO blood group system involves two antigens and two antibodies found in human blood. The two antigens are antigen A and antigen B. The two antibodies are antibody A and antibody B. The antigens are present on the red blood cells and the antibodies in the serum. Regarding the antigen property of the blood all human beings can be classified into four groups, those with antigen A (group A), those with antigen B (group B), those with both antigen A and B (group AB) and those with neither antigen (group O). The antibodies present together with the antigens are found as follows:
Antigen A with antibody B
Antigen B with antibody A
Antigen AB with neither antibody A nor B
Antigen null (group O) with both antibody A and BThere is an agglutination reaction between similar antigen and antibody (for example, antigen A agglutinates the antibody A and antigen B agglutinates the antibody B). Thus, transfusion can be considered safe as long as the serum of the recipient does not contain antibodies for the blood cell antigens of the donor.The ABO system is the most important blood-group system in human-blood transfusion. The associated anti-A and anti-B antibodies are usually immunoglobulin M, abbreviated IgM, antibodies. It has been hypothesized that ABO IgM antibodies are produced in the first years of life by sensitization to environmental substances such as food, bacteria, and viruses, although blood group compatibility rules are applied to newborn and infants as a matter of practice. The original terminology used by Karl Landsteiner in 1901 for the classification was A/B/C; in later publications "C" became "O". Type O is often called 0 (zero, or null) in other languages.

Rh blood group system
The Rh system (Rh meaning Rhesus) is the second most significant blood-group system in human-blood transfusion with currently 50 antigens. The most significant Rh antigen is the D antigen, because it is the most likely to provoke an immune system response of the five main Rh antigens. It is common for D-negative individuals not to have any anti-D IgG or IgM antibodies, because anti-D antibodies are not usually produced by sensitization against environmental substances. However, D-negative individuals can produce IgG anti-D antibodies following a sensitizing event: possibly a fetomaternal transfusion of blood from a fetus in pregnancy or occasionally a blood transfusion with D positive RBCs. Rh disease can develop in these cases. Rh negative blood types are much less common in Asian populations (0.3%) than they are in European populations (15%).The presence or absence of the Rh(D) antigen is signified by the + or − sign, so that, for example, the A− group is ABO type A and does not have the Rh (D) antigen.

ABO and Rh distribution by country
As with many other genetic traits, the distribution of ABO and Rh blood groups varies significantly between populations. While theories are still debated in the scientific community as to why blood types vary geographically and why they emerged in the first place, evidence suggests that the evolution of blood types may be driven by genetic selection for those types whose antigens confer resistance to particular diseases in certain regions – such as the prevalence of blood type O in malaria-endemic countries where individuals of blood type O exhibit the highest rates of survival.

Other blood group systems
As of December 2022, 42 blood-group systems have been identified by the International Society for Blood Transfusion in addition to the ABO and Rh systems. Thus, in addition to the ABO antigens and Rh antigens, many other antigens are expressed on the RBC surface membrane. For example, an individual can be AB, D positive, and at the same time M and N positive (MNS system), K positive (Kell system), Lea or Leb negative (Lewis system), and so on, being positive or negative for each blood group system antigen. Many of the blood group systems were named after the patients in whom the corresponding antibodies were initially encountered. Blood group systems other than ABO and Rh pose a potential, yet relatively low, risk of complications upon mixing of blood from different people.Following is a comparison of clinically relevant characteristics of antibodies against the main human blood group systems:

Clinical significance
Blood transfusion
Transfusion medicine is a specialized branch of hematology that is concerned with the study of blood groups, along with the work of a blood bank to provide a transfusion service for blood and other blood products. Across the world, blood products must be prescribed by a medical doctor (licensed physician or surgeon) in a similar way as medicines.
Much of the routine work of a blood bank involves testing blood from both donors and recipients to ensure that every individual recipient is given blood that is compatible and as safe as possible. If a unit of incompatible blood is transfused between a donor and recipient, a severe acute hemolytic reaction with hemolysis (RBC destruction), kidney failure and shock is likely to occur, and death is a possibility. Antibodies can be highly active and can attack RBCs and bind components of the complement system to cause massive hemolysis of the transfused blood.Patients should ideally receive their own blood or type-specific blood products to minimize the chance of a transfusion reaction. It is also possible to use the patient's own blood for transfusion. This is called autologous blood transfusion, which is always compatible with the patient. The procedure of washing a patient's own red blood cells goes as follows: The patient's lost blood is collected and washed with a saline solution. The washing procedure yields concentrated washed red blood cells. The last step is reinfusing the packed red blood cells into the patient. There are multiple ways to wash red blood cells. The two main ways are centrifugation and filtration methods. This procedure can be performed with microfiltration devices like the Hemoclear filter. Risks can be further reduced by cross-matching blood, but this may be skipped when blood is required for an emergency. Cross-matching involves mixing a sample of the recipient's serum with a sample of the donor's red blood cells and checking if the mixture agglutinates, or forms clumps. If agglutination is not obvious by direct vision, blood bank technologist usually check for agglutination with a microscope. If agglutination occurs, that particular donor's blood cannot be transfused to that particular recipient.  In a blood bank it is vital that all blood specimens are correctly identified, so labelling has been standardized using a barcode system known as ISBT 128.
The blood group may be included on identification tags or on tattoos worn by military personnel, in case they should need an emergency blood transfusion. Frontline German Waffen-SS had blood group tattoos during World War II.
Rare blood types can cause supply problems for blood banks and hospitals. For example, Duffy-negative blood occurs much more frequently in people of African origin, and the rarity of this blood type in the rest of the population can result in a shortage of Duffy-negative blood for these patients.  Similarly, for RhD negative people there is a risk associated with travelling to parts of the world where supplies of RhD negative blood are rare, particularly East Asia, where blood services may endeavor to encourage Westerners to donate blood.

Hemolytic disease of the newborn (HDN)
A pregnant woman may carry a fetus with a blood type which is different from her own. Typically, this is an issue if a Rh- mother has a child with a Rh+ father, and the fetus ends up being Rh+ like the father. In those cases, the mother can make IgG blood group antibodies. This can happen if some of the fetus' blood cells pass into the mother's blood circulation (e.g. a small fetomaternal hemorrhage at the time of childbirth or obstetric intervention), or sometimes after a therapeutic blood transfusion.  This can cause Rh disease or other forms of hemolytic disease of the newborn (HDN) in the current pregnancy and/or subsequent pregnancies.  Sometimes this is lethal for the fetus; in these cases it is called hydrops fetalis. If a pregnant woman is known to have anti-D antibodies, the Rh blood type of a fetus can be tested by analysis of fetal DNA in maternal plasma to assess the risk to the fetus of Rh disease. One of the major advances of twentieth century medicine was to prevent this disease by stopping the formation of Anti-D antibodies by D negative mothers with an injectable medication called Rho(D) immune globulin. Antibodies associated with some blood groups can cause severe HDN, others can only cause mild HDN and others are not known to cause HDN.

Blood products
To provide maximum benefit from each blood donation and to extend shelf-life, blood banks fractionate some whole blood into several products. The most common of these products are packed RBCs, plasma, platelets, cryoprecipitate, and fresh frozen plasma (FFP).  FFP is quick-frozen to retain the labile clotting factors V and VIII, which are usually administered to patients who have a potentially fatal clotting problem caused by a condition such as advanced liver disease, overdose of anticoagulant, or disseminated intravascular coagulation (DIC).Units of packed red cells are made by removing as much of the plasma as possible from whole blood units.
Clotting factors synthesized by modern recombinant methods are now in routine clinical use for hemophilia, as the risks of infection transmission that occur with pooled blood products are avoided.

Red blood cell compatibility
Blood group AB  individuals have both A and B antigens on the surface of their RBCs, and their blood plasma does not contain any antibodies against either A or B antigen. Therefore, an individual with type AB blood can receive blood from any group (with AB being preferable), but cannot donate blood to any group other than AB.  They are known as universal recipients.
Blood group A  individuals have the A antigen on the surface of their RBCs, and blood serum containing IgM antibodies against the B antigen. Therefore, a group A individual can receive blood only from individuals of groups A or O (with A being preferable), and can donate blood to individuals with type A or AB.
Blood group B  individuals have the B antigen on the surface of their RBCs, and blood serum containing IgM antibodies against the A antigen. Therefore, a group B individual can receive blood only from individuals of groups B or O (with B being preferable), and can donate blood to individuals with type B or AB.
Blood group O (or blood group zero in some countries) individuals do not have either A or B antigens on the surface of their RBCs, and their blood serum contains IgM anti-A and anti-B antibodies. Therefore, a group O individual can receive blood only from a group O individual, but can donate blood to individuals of any ABO blood group (i.e., A, B, O or AB). If a patient needs an urgent blood transfusion, and if the time taken to process the recipient's blood would cause a detrimental delay, O negative blood can be issued. Because it is compatible with anyone, O negative blood is often overused and consequently is always in short supply. According to the American Association of Blood Banks and the British Chief Medical Officer's National Blood Transfusion Committee, the use of group O RhD negative red cells should be restricted to persons with O negative blood, women who might be pregnant, and emergency cases in which blood-group testing is genuinely impracticable.
Table note
1. Assumes absence of atypical antibodies that would cause an incompatibility between donor and recipient blood, as is usual for blood selected by cross matching.

An Rh D-negative patient who does not have any anti-D antibodies (never being previously sensitized to D-positive RBCs) can receive a transfusion of D-positive blood once, but this would cause sensitization to the D antigen, and a female patient would become at risk for hemolytic disease of the newborn.  If a D-negative patient has developed anti-D antibodies, a subsequent exposure to D-positive blood would lead to a potentially dangerous transfusion reaction. Rh D-positive blood should never be given to D-negative women of child-bearing age or to patients with D antibodies, so blood banks must conserve Rh-negative blood for these patients. In extreme circumstances, such as for a major bleed when stocks of D-negative blood units are very low at the blood bank, D-positive blood might be given to D-negative females above child-bearing age or to Rh-negative males, providing that they did not have anti-D antibodies, to conserve D-negative blood stock in the blood bank. The converse is not true; Rh D-positive patients do not react to D negative blood.
This same matching is done for other antigens of the Rh system as C, c, E and e and for other blood group systems with a known risk for immunization such as the Kell system in particular for females of child-bearing age or patients with known need for many transfusions.

Plasma compatibility
Blood plasma compatibility is the inverse of red blood cell compatibility. Type AB plasma carries neither anti-A nor anti-B antibodies and can be transfused to individuals of any blood group; but type AB patients can only receive type AB plasma. Type O carries both antibodies, so individuals of blood group O can receive plasma from any blood group, but type O plasma can be used only by type O recipients.

Table note
1. Assuming absence of strong atypical antibodies in donor plasma

Rh D antibodies are uncommon, so generally neither D negative nor D positive blood contain anti-D antibodies.  If a potential donor is found to have anti-D antibodies or any strong atypical blood group antibody by antibody screening in the blood bank, they would not be accepted as a donor (or in some blood banks the blood would be drawn but the product would need to be appropriately labeled); therefore, donor blood plasma issued by a blood bank can be selected to be free of D antibodies and free of other atypical antibodies, and such donor plasma issued from a blood bank would be suitable for a recipient who may be D positive or D negative, as long as blood plasma and the recipient are ABO compatible.

Universal donors and universal recipients
In transfusions of packed red blood cells, individuals with type O Rh D negative blood are often called universal donors. Those with type AB Rh D positive blood are called universal recipients. However, these terms are only generally true with respect to possible reactions of the recipient's anti-A and anti-B antibodies to transfused red blood cells, and also possible sensitization to Rh D antigens. One exception is individuals with hh antigen system (also known as the Bombay phenotype) who can only receive blood safely from other hh donors, because they form antibodies against the H antigen present on all red blood cells.Blood donors with exceptionally strong anti-A, anti-B or any atypical blood group antibody may be excluded from blood donation. In general, while the plasma fraction of a blood transfusion may carry donor antibodies not found in the recipient, a significant reaction is unlikely because of dilution.
Additionally, red blood cell surface antigens other than A, B and Rh D, might cause adverse reactions and sensitization, if they can bind to the corresponding antibodies to generate an immune response.  Transfusions are further complicated because platelets and white blood cells (WBCs) have their own systems of surface antigens, and sensitization to platelet or WBC antigens can occur as a result of transfusion.
For transfusions of plasma, this situation is reversed.  Type O plasma, containing both anti-A and anti-B antibodies, can only be given to O recipients.  The antibodies will attack the antigens on any other blood type.  Conversely, AB plasma can be given to patients of any ABO blood group, because it does not contain any anti-A or anti-B antibodies.

Blood typing
Typically, blood type tests are performed through addition of a blood sample to a solution containing antibodies corresponding to each antigen. The presence of an antigen on the surface of the blood cells is indicated by agglutination.

Blood group genotyping
In addition to the current practice of serologic testing of blood types, the progress in molecular diagnostics allows the increasing use of blood group genotyping. In contrast to serologic tests reporting a direct blood type phenotype, genotyping allows the prediction of a phenotype based on the knowledge of the molecular basis of the currently known antigens. This allows a more detailed determination of the blood type and therefore a better match for transfusion, which can be crucial in particular for patients with needs for many transfusions to prevent allo-immunization.

History
Blood types were first discovered by an Austrian physician, Karl Landsteiner, working at the Pathological-Anatomical Institute of the University of Vienna (now Medical University of Vienna). In 1900, he found that blood sera from different persons would clump together (agglutinate) when mixed in test tubes, and not only that, some human blood also agglutinated with animal blood. He wrote a two-sentence footnote:

The serum of healthy human beings not only agglutinates animal red cells, but also often those of human origin, from other individuals. It remains to be seen whether this appearance is related to inborn differences between individuals or it is the result of some damage of bacterial kind.
This was the first evidence that blood variation exists in humans. The next year, in 1901, he made a definitive observation that blood serum of an individual would agglutinate with only those of certain individuals. Based on this he classified human bloods into three groups, namely group A, group B, and group C. He defined that group A blood agglutinates with group B, but never with its own type. Similarly, group B blood agglutinates with group A. Group C blood is different in that it agglutinates with both A and B. This was the discovery of blood groups for which Landsteiner was awarded the Nobel Prize in Physiology or Medicine in 1930. (C was later renamed to O after the German Ohne, meaning without, or zero, or null.) Another group (later named AB) was discovered a year later by Landsteiner's students Adriano Sturli and Alfred von Decastello without designating the name (simply referring it to as "no particular type"). Thus, after Landsteiner, three blood types were initially recognised, namely A, B, and C.Czech serologist Jan Janský was the first to recognise and designate four blood types in 1907 that he published in a local journal, using the Roman numerical I, II, III, and IV (corresponding to modern O, A, B, and AB respectively). Unknown to Janský, an American physician William L. Moss introduced almost identical classification in 1910; but his I and IV corresponding Janský's IV and I. Moss came across Janský's paper as his was being printed, mentioned it in a footnote. Thus the existence of two systems immediately created confusion and potential danger in medical practice. Moss's system was adopted in Britain, France, and the US, while Janský's was preferred in most other European countries and some parts of the US. It was reported that "The practically universal use of the Moss classification at that time was completely and purposely cast aside. Therefore in place of bringing order out of chaos, chaos was increased in the larger cities." To resolve the confusion, the American Association of Immunologists, the Society of American Bacteriologists, and the Association of Pathologists and Bacteriologists made a joint recommendation in 1921 that the Jansky classification be adopted based on priority. But it was not followed particularly where Moss's system had been used.In 1927, Landsteiner, who had moved to the Rockefeller Institute for Medical Research in New York, and as a member of a committee of the National Research Council concerned with blood grouping suggested to substitute Janský's and Moss's systems with the letters O, A, B, and AB. There was another confusion on the use of O which was introduced by Polish physicians Ludwik Hirszfeld and German physician Emil von Dungern in 1910. It was never clear whether it was meant for the figure 0, German null for zero or the upper case letter O for ohne, meaning without; Landsteiner chose the latter.
In 1928 the Permanent Commission on Biological Standardization adopted Landsteiner's proposal and stated:The Commission learns with satisfaction that, on the initiative of the Health Organization of the League of Nations, the nomenclature proposed by von Dungern and Hirszfeld for the classification of blood groups has been generally accepted, and recommends that this nomenclature shall be adopted for international use as follows: 0 A B AB. To facilitate the change from the nomenclature hitherto employed the following is suggested:
Jansky ....0(I) A(II) B(III) AB(IV)
Moss ... O(IV) A(II) B(III) AB(I)This classification became widely accepted and after the early 1950s it was universally followed.Hirszfeld and Dungern discovered the inheritance of blood types as Mendelian genetics in 1910 and the existence of sub-types of A in 1911. In 1927, Landsteiner, with Philip Levine, discovered the MN blood group system, and the P system. Development of the Coombs test in 1945, the advent of transfusion medicine, and the understanding of ABO hemolytic disease of the newborn led to discovery of more blood groups. As of December 2023, the International Society of Blood Transfusion (ISBT) recognizes 45 blood groups.

Society and culture
A popular pseudoscientific belief in Eastern Asian countries (especially in Japan and South Korea) known as 血液型 ketsuekigata / hyeoraekhyeong is that a person's ABO blood type is predictive of their personality, character, and compatibility with others. Researchers have established no scientific basis exists for blood type personality categorization, and studies have found no "significant relationship between personality and blood type, rendering the theory 'obsolete' and concluding that no basis exists to assume that personality is anything more than randomly associated with blood type."

See also
Blood type (non-human)
Human leukocyte antigen
hh blood group

References
Further reading
Dean, Laura (2005). Blood Groups and Red Cell Antigens, a guide to the differences in our blood types that complicate blood transfusions and pregnancy. Bethesda MD: National Center for Biotechnology Information. ISBN 1-932811-05-2. NBK2261.
Mollison PL, Engelfriet CP, Contreras M (1997). Blood Transfusion in Clinical Medicine (10th ed.). Oxford UK: Blackwell Science. ISBN 0-86542-881-6.

External links

BGMUT Blood Group Antigen Gene Mutation Database at NCBI, NIH has details of genes and proteins, and variations thereof, that are responsible for blood types
Online Mendelian Inheritance in Man (OMIM): ABO Glycosyltransferase; ABO - 110300
Online Mendelian Inheritance in Man (OMIM): Rhesus Blood Group, D Antigen; RHD - 111680
"Blood group test". Gentest.ch GmbH. Archived from the original on 2017-03-24. Retrieved 2017-03-23.
"Blood Facts – Rare Traits". LifeShare Blood Centers. Archived from the original on September 26, 2006. Retrieved September 15, 2006.
"Modern Human Variation: Distribution of Blood Types". Dr. Dennis O'Neil, Behavioral Sciences Department, Palomar College, San Marcos, California. 2001-06-06. Archived from the original on 2001-06-06. Retrieved November 23, 2006.
"Racial and Ethnic Distribution of ABO Blood Types – BloodBook.com, Blood Information for Life". bloodbook.com. Archived from the original on 2010-03-04. Retrieved September 15, 2006.
"Molecular Genetic Basis of ABO". Retrieved July 31, 2008.


In genetics, a centimorgan (abbreviated cM) or map unit (m.u.) is a unit for measuring genetic linkage.  It is defined as the distance between chromosome positions (also termed loci or markers) for which the expected average number of intervening chromosomal crossovers in a single generation is 0.01.  It is often used to infer distance along a chromosome. However, it is not a true physical distance.

Relation to physical distance
The number of base pairs to which it corresponds varies widely across the genome (different regions of a chromosome have different propensities towards crossover) and it also depends on whether the meiosis in which the crossing-over takes place is a part of oogenesis (formation of female gametes) or spermatogenesis (formation of male gametes).
One centimorgan corresponds to about 1 million base pairs in humans on average. The relationship is only rough, as the physical chromosomal distance corresponding to one centimorgan varies from place to place in the genome, and also varies between males and females since recombination during gamete formation in females is significantly more frequent than in males. Kong et al. calculated that the female genome is 4460 cM long, while the male genome is only 2590 cM long. Plasmodium falciparum has an average recombination distance of ~15 kb per centimorgan: markers separated by 15 kb of DNA (15,000 nucleotides) have an expected rate of chromosomal crossovers of 0.01 per generation. Note that non-syntenic genes (genes residing on different chromosomes) are inherently unlinked, and cM distances are not applicable to them.

Relation to the probability of recombination
Because genetic recombination between two markers is detected only if there are an odd number of chromosomal crossovers between the two markers, the distance in centimorgans does not correspond exactly to the probability of genetic recombination.  Assuming J. B. S. Haldane's map function, in which the number of chromosomal crossovers is distributed according to a Poisson distribution, a genetic distance of d centimorgans will lead to an odd number of chromosomal crossovers, and hence a detectable genetic recombination, with probability

        P
        (

          recombination

          |

          linkage of

        d

           cM

        )
        =

          ∑

            k
            =
            0

            ∞

        P
        (
        2
        k
        +
        1

           crossovers

          |

          linkage of

        d

           cM

        )

    {\displaystyle \ P({\text{recombination}}|{\text{linkage of }}d{\text{ cM}})=\sum _{k=0}^{\infty }\ P(2k+1{\text{ crossovers}}|{\text{linkage of }}d{\text{ cM}})}

        =

          ∑

            k
            =
            0

            ∞

          e

            −
            d

              /

            100

              (
              d

                /

              100

                )

                  2

                  k
                  +
                  1

              (
              2

              k
              +
              1
              )
              !

        =

          e

            −
            d

              /

            100

        sinh

        (
        d

          /

        100
        )
        =

              1
              −

                e

                  −
                  2
                  d

                    /

                  100

            2

        ,

    {\displaystyle {}=\sum _{k=0}^{\infty }e^{-d/100}{\frac {(d/100)^{2\,k+1}}{(2\,k+1)!}}=e^{-d/100}\sinh(d/100)={\frac {1-e^{-2d/100}}{2}}\,,}
  where sinh is the hyperbolic sine function.  The probability of recombination is approximately d/100 for small values of d and approaches 50% as d goes to infinity.
The formula can be inverted, giving the distance in centimorgans as a function of the recombination probability:

        d
        =
        50
        ln

          (

              1

                1
                −
                2

                P
                (

                  recombination

                )

          )

        .

    {\displaystyle d=50\ln \left({\frac {1}{1-2\ P({\text{recombination}})}}\right)\,.}

Etymology
The centimorgan was named in honor of geneticist Thomas Hunt Morgan by J. B. S. Haldane. However, its parent unit, the morgan, is rarely used today.

See also
Mutation rate

References

== Further reading ==


Chemogenetics is the process by which macromolecules can be engineered to interact with previously unrecognized small molecules. Chemogenetics as a term was originally coined to describe the observed effects of mutations on chalcone isomerase activity on substrate specificities in the flowers of Dianthus caryophyllus. This method is very similar to optogenetics; however, it uses chemically engineered molecules and ligands instead of light and light-sensitive channels known as opsins.
In recent research projects, chemogenetics has been widely used to understand the relationship between brain activity and behavior. Prior to chemogenetics, researchers used methods such as transcranial magnetic stimulation and deep brain stimulation to study the relationship between neuronal activity and behavior.

Comparison to optogenetics
Optogenetics and chemogenetics are the more recent and popular methods used to study this relationship. Both of these methods target specific brain circuits and cell population to influence cell activity. However, they use different procedures to accomplish this task. Optogenetics uses light-sensitive channels and pumps that are virally introduced into neurons. Cells' activity, having these channels, can then be manipulated by light. Chemogenetics, on the other hand, uses chemically engineered receptors and exogenous molecules specific for those receptors, to affect the activity of those cells. The engineered macromolecules used to design these receptors include nucleic acid hybrids, kinases, variety of metabolic enzymes, and G-protein coupled receptors such as DREADDs.DREADDs are the most common G protein–coupled receptors used in chemogenetics. These receptors solely get activated by the drug of interest (inert molecule) and influence physiological and neural processes that take place within and outside of the central nervous system.Chemogenetics has recently been favored over optogenetics, and it avoids some of the challenges of optogenetics. Chemogenetics does not require the expensive light equipment, and therefore, is more accessible. The resolution in Optogenetic declines due to light scattering and illuminance declined levels as the distance between the subject and the light source increases. These factors, therefore, don’t allow for all cells to be affected by light and lead to a lower spatial resolution. Chemogenetics, however, does not require light usage and therefore can achieve a higher spatial resolution.

Applications
G-protein coupled receptors' usage and chemogenetics are nowadays the targets for many of the pharmaceutical companies to cure and alleviate symptoms of diseases that involve all tissues of the body. More specifically, DREADDs have been used to explore treatment options for various neurodegenerative and psychological conditions such as Parkinson’s disease, depression, anxiety, and addiction. These aforementioned conditions involve processes that occur within and outside of the nervous system involving neurotransmitters such as gamma-aminobutyric acid and glutamate. Chemogenetics has therefore been used in pharmacology to adjust the levels of such neurotransmitters in specific neuron while minimizing the side effects of treatment. To treat and relieve the symptoms of any disease using the DREADDs, these receptors are delivered to the area of interest via viral transduction.Recently some studies have considered using a new method called retro DREADDs. This method allows specific neuronal pathways to be studied under cellular resolution. Unlike classic DREADDs, this method is usually used in wild type animals, and these receptors are given to the targeted cells via injection of two viral vectors.

Animal Models
DREADDS have been used in many animal models (e.g., mice and other non-primate animals) to target and influence the activity of various cells. Chemogenetics used in animals assists with demonstrating human disease models such as Parkinson's disease. Having this information allows scientists understand whether viral expression of DREADD proteins, both in-vivo enhancers and inhibitors of neuronal function can be used to bidirectionally affect the behaviors and the activity of the involved neurons. Recent studies have shown that DREADDs were successfully used to treat the motor deficits of rats modeling Parkinson's disease. Other studies have had successes linking the usage of DREADDs and influencing drug seeking and drug sensitization behavior.The progression of chemogenetics from rodents to non-human primates has been slow due to increased demand in time and expense surrounding these projects. However, some recent studies in 2016 have been able to demonstrate successes showing that silencing the activity of neurons in the orbitofrontal cortex along with the removal of rhinal cortex, restricted the reward task performance in macaques.

Limitation and future directions
Chemogenetics and usage of DREADDs have allowed researchers to advance in biomedical research areas including many neurodegenerative and psychiatric conditions. Chemogenetics have been used in these fields to induce specific and reversible brain lesions and therefore, study specific activities of neuron population. Although chemogenetics offers specificity and high spatial resolution, it still faces some challenges when used in investigating neuropsychiatric disorders. Neuropsychiatric disorders usually have a complex nature where lesions in the brain have not been identified as the main cause. Chemogenetics has been used to reverse some of the deficits revolving such conditions; however, it has not been able to identify the main cause of neuropsychiatric diseases and cure these conditions completely due to complex nature of these conditions. Nevertheless, chemogenetics has been used successfully in a preclinical model of drug-resistant epilepsy, where seizures arise from a discrete part of the brain.

See also
Receptor activated solely by a synthetic ligand

== References ==


Color Health, Inc. is a population health technology company which provides genetic tests and analysis directly to patients as well as through employers. The product focuses on genes that indicate risk for heart disease, cancer, and that affect medication response.

History
The company was co-founded in 2015 by Elad Gil, Nish Bhat, Taylor Sittler, and Othman Laraki, who now serves as company CEO, in Burlingame, California.
In November 2021, the company had a valuation of $4.6B and collected $100 million in a series E financing round.

Expansion to population health
Color provides technology, software, and clinical services for population health programs.
Color has partnered with health systems including NorthShore University Health System, Ochsner Health System, and Jefferson Health.

COVID-19 testing programs
In early 2020, recognizing the growing threat that the COVID-19 pandemic presented, Color mobilized its existing software, logistics expertise and lab operations to focus on mass COVID-19 testing.Color operates a high-throughput CLIA-certified COVID-19 testing laboratory and processes thousands of samples a day. The integrated process includes sign up, the self-collection kit, and results returned via text and email to patients, clinicians, and public health authorities. Color returns results, on average, within 24–48 hours.In August 2020, Color was running some of the highest-capacity test sites in the country. Color was also responsible for the majority of San Francisco’s COVID-19 testing with an average turnaround time within 24 hours, and most results returned in under 48 hours. Color worked with San Francisco’s CityTestSF program, Alameda County Health Services and federally qualified health centers in Alameda County, Marin County and others. The company has also partnered with a wide variety of universities, employers and public health entities, including USC and United Airlines.In January 2022, Color had computer difficulties that resulted in delayed test results and closed testing stations.

Testing system
Genetics
Color’s physician-ordered test can be initiated by individuals online, and a sample collection kit is sent in the mail. Individuals provide a saliva sample and return the kit in a pre-paid package. Color's CLIA-certified and CAP-approved lab analyzes for variants in the breast cancer genes BRCA1 and BRCA2, as well as 28 other genes associated with breast, prostate, colon, uterine, stomach, melanoma, pancreatic, and ovarian cancers. The test also identifies variants in 30 genes related to hereditary heart conditions as well as genes that may impact medication response. Genetic counseling with board-certified genetic counselors is available for free to all individuals who use Color.

COVID-19
Color’s FDA Emergency Use Authorization (EUA) COVID-19 test can be accessed as a part of testing programs initiated by a public health entity, university, employer or other organization. The test is a dry anterior nasal swab, approved for use either in an on-site or at-home setting without the need for a healthcare provider to monitor sample collection, which eases the burden on the healthcare system and reduces testing costs.The company has received an FDA EUA for the testing assay, which is a nucleic acid amplification method called LAMP, or loop-mediated isothermal amplification. This enables processing test results 50% faster than RT-PCR, the amplification method used at most other labs. LAMP relies on a different set of chemical reagents than standard PCR tests, which helps the process avoids supply chain scarcity.

Research
In 2018, Color was selected, alongside the Broad Institute of MIT and Harvard, and the Laboratory for Molecular Medicine (LMM) at Partners HealthCare, to establish one of three genome centers around the country for the National Institutes of Health’s historic All of Us Research Program. All of Us will sequence one million or more people across the US, with the goal of accelerating health research and enabling individualized prevention, treatment, and care. The program has a focus on recruitment from populations that have been historically underrepresented in clinical science and genomic medicine, in order to build a diverse biomedical data resource that provides a foundation for better insights into the biological, environmental, and behavioral factors that influence health.In 2019, Color was named the sole awardee to deliver all of the genetic counseling for All of Us. As the awardee, Color will customize software and tools to integrate data from all the genome centers, standardize reporting across the program, and ensure all results are returned in a unified way. This is a first year $4.6 million grant as part of a multi-year $25 million project.
In collaboration with the Women’s Health Initiative and Dr. Mary-Claire King at the University of Washington, Color provided genetic sequencing for the cohort of 10,000 Fabulous Ladies Over Seventy (FLOSSIES). This is the largest publicly available dataset of genetic variants associated with hereditary cancer in healthy, older individuals.Color Data, a database containing aggregated genetic and clinical information from 50,000 individuals who took a Color test, helps researchers and scientists identify genotype-phenotype correlations and novel variants for functional analysis, as well as enables data-driven drug discovery and development. It is the largest public database of its kind.As a part of the MAGENTA Study, which aims to improve availability of genetic testing for hereditary cancer syndromes to at-risk individuals through the use of an online genetic testing service, Color is working with a Stand Up to Cancer Dream Team that includes physicians, scientists and researchers from the MD Anderson Cancer Center and the University of Washington to provide genetic counseling to high-risk individuals through delivery models such as tele-counseling.In collaboration with Dr. Laura Esserman at University of California and Sanford Health, Color is providing genetic testing for WISDOM, a 100,000-woman study that is comparing annual screenings with personalized, risk-based breast cancer screenings.As part of the GENtleMEN Study, Color is working with Dr. Heather Cheng at the Fred Hutchinson Cancer Research Center and the University of Washington to provide genetic testing and counseling to men with advanced prostate cancer.Color contributes anonymized variants to ClinVar, a free database managed by the National Center for Biotechnology Information (NCBI) at the National Institutes of Health (NIH) that helps researchers identify links between genes and disease.Color's research collaborators include:
Mary-Claire King: advisor, scientific collaborator
Sekar Kathiresan: advisor, scientific collaborator
Heidi Rehm: scientific collaborator

== References ==


In genetics, two organisms that differ in only one locus and a linked segment of chromosome are defined as congenic. Similarly, organisms that are coisogenic differ in one locus only and not in the surrounding chromosome. Unlike congenic organisms, coisogenic organisms cannot be bred and only occur through spontaneous or targeted mutation at the locus.

Generating congenic strains
Congenic strains are generated in the laboratory by mating two inbred strains (usually rats or mice), and back-crossing the descendants 5–10 generations with one of the original strains, known as the recipient strain. Typically selection for either phenotype or genotype is performed prior to each back-cross generation. In this manner either an interesting phenotype, or a defined chromosomal region assayed by genotype, is passed from the donor strain onto an otherwise uniform recipient background.  Congenic mice or rats can then be compared to the pure recipient strain to determine whether they are phenotypically different if selection was for a genotypic region, or to identify the critical genetic locus, if selection was for a phenotype.
Speed congenics can be produced in as little as five back-cross generations, through the selection at each generation of offspring that not only retain the desired chromosomal fragment, but also 'lose' the maximum amount of background genetic information from the donor strain. This is also known as marker-assisted congenics, due to the use of genetic markers, typically microsatellite markers, but now, more commonly, single nucleotide polymorphism markers (SNPs). The process can be further aided by the superovulation of females, to produce many more eggs.

See also
Gene knockout

Notes and references
Further reading
Congenic strains are discussed in detail in Lee Silver's online book Mouse Genetics: Concepts and Applications:

"Mouse Genetics: Concepts and Applications". Lee Silver. Retrieved 2007-10-18.[1]


Cotransformation is the simultaneous transformation of two or more genes.
Only genes in the same chromosomal vicinity can be transformed; the closer together the genes lie, the more frequently they will be cotransformed. By contrast, genes sufficiently far apart that they cannot appear together on a fragment of foreign DNA will almost never be cotransformed, because transformation is so inefficient that recipient cells usually take up only a single DNA.

Example
In one study of natural transformation, investigators isolated B. subtilis bacteria with two mutations—trpC2 and hisB2—that made them Trp- , His- auxotrophs. These double auxotrophs served as the recipient in the study, wild-type cells (Trp+ , His+ ) were the donors. In this study, the numbers of Trp+ and His+  transformants were equal. Further tests showed that 40 of every 100 Trp+ transferred colonies were also His+. Similarly, tests of the His+ transformants showed that roughly 40% are also Trp+ . Thus, in 40% of the analyzed colonies, the trpC+ and hisB+ genes had been cotransformed.

Explanation
Since during transformation, donor DNA replaces only a small percentage of the recipient's chromosome, why are the two B.subtilis genes cotransformed with such high frequency? Because the trpC and hisB genes lie very close together on the chromosome and are thus genetically linked. Although the donor chromosome is fragmented into small pieces of about 20 kb during its extraction for the transformation process, the wild-type trpC+ and hisB+ alleles are so close that they often appear in the same donor DNA molecule. Sequence analysis shows that trpC and hisB genes are only about 7 kb apart.

== References ==


Countergradient variation is a type of phenotypic plasticity that occurs when the phenotypic variation determined by a biological population's genetic components opposes the phenotypic variation caused by an environmental gradient. This can cause different populations of the same organism to display similar phenotypes regardless of their underlying genetics and differences in their environments.To illustrate a common example known as countergradient growth rate, consider two populations. The two populations live in different environments that affect growth differently due to many ecological factors, such as the temperature and available food. One population is genetically predisposed to have an increased growth rate but inhabits an environment that reduces growth rate, such as a cool environment, and thereby limits the opportunities to take full advantage of any genetic predisposition. The second population is genetically predisposed to have a decreased growth rate but inhabits an environment that supports an increased growth rate, such as a warm environment, and allows members of the population to grow faster despite their genetic disadvantage. Since the genetic influence directly counteracts the environmental influence in each population, both populations will have a similar intermediate growth rate. Countergradient variation can reduce apparent variability by creating similar phenotypes, but it is still possible for the two populations to show phenotypic diversity if either the genetic gradient or the environmental gradient has a stronger influence.
Many examples of countergradient variation have been discovered through the use of transplant experiments. Countergradient variation of growth rate is one of the most common examples. Growth rate and body size have important ecological implications, such as how they impact an organism's survival, life history, and fecundity. Countergradient variation has been described in many ectothermic animals, since ectotherms rely on environmental temperature to regulate their metabolic rates, and thus, their growth rates. Ectotherms grow at a slower rate as latitude increases due to this impact of temperature. However, under countergradient variation, when these same animals are placed in a common environment with their low-latitude relatives, they grow faster relative to the low-latitude population. These studies are useful in predicting how animals can adapt to and will survive in different environmental conditions.

History
Countergradient variation, originally termed "contra-gradient variation", was coined by Richard Levins in his 1968 book Evolution in Changing Environments.  Levins first used the term when describing patterns of body size across an altitudinal gradient in populations of Drosophila, and since then many other instances of countergradient variation have been discovered. A study by Keith Berven and others was the first to find countergradient variation in a vertebrate. Specifically, they found that in comparing montane, high altitude, populations to lowland, low altitude populations of the green frog (Lithobates clamitans, formerly Rana clamitans), rates of growth and development were higher in the montane populations. This is counter to what is expected since high altitude populations grow slower than low altitude ones in their respective environments. Similar to the results of this study, most of the known instances of countergradient variation are associated with a latitudinal or altitudinal gradient having an effect on growth rate (see Examples section).

Examples
The following are among the discovered cases of countergradient variation. The species name is followed by the trait affected and the environmental gradient studied.

Animals
Drosophila melanogaster – body size; altitude
Menidia menidia – growth; latitude
Lithobates clamitans – developmental rate; altitude
Lithobates sylvatica – growth; latitude and altitude
Sceloporus undulatus – growth; latitude

Plants
Laminaria saccharina – growth; latitude
Carex aquatilis – shoot height; temperature and latitude
Spartina angilca – growth and survival; tide elevation and succession stage

Mechanisms
Countergradient variation is the opposite of cogradient variation, in which the environmental effect on the phenotype enhances the genetic effect on the phenotype. One common way to test for both of these patterns is with transplant experiments. By bringing the two populations to the same environment, the environmental effect on phenotype is eliminated and only the genetic effect will cause variation. If cogradient variation is occurring, the same relationship will be seen in the common environment as the two natural environments. However, if countergradient variation is occurring the opposite relationship of what is seen in the natural environments will be seen in the common environment. For example, if Population 1 has higher growth than Population 2 in their respective natural environments, countergradient variation can be detected if, when brought to the same environment, Population 1 now has lower growth than Population 2. Many of the examples listed above were discovered through these types of experiments. However, the mechanisms of how these differential growth rates arise is not fully understood.
Take the example of Sceloporus undulatus, the eastern fence lizard. These lizards demonstrate countergradient variation in growth rate across a latitudinal gradient. That is, in a common environment eggs from populations from the northern part of their range hatch out sooner than the eggs from populations at a more southern range. This is opposite the pattern seen in their native habitats. One explanation for this could be that the northern eggs are also naturally larger, so they have more yolk energy available. Originally this maternal investment in larger eggs was thought to support increased developmental rate. However when yolk is removed from the eggs so that the populations have equal energy sources, there is still a substantial difference in growth. Therefore, the mechanism behind this differential growth rate may lie in the efficiency of energy use.

Ecological relevance
Populations that inhabit high latitudes experience shorter growing seasons than those that inhabit low latitudes due to the differences in seasonality. Because of this, it is thought that countergradient variation of growth is a means to compensate for the short amount of time juveniles have to prepare for winter. With a genetic disposition to grow faster, these individuals can reach a large enough body size to survive through the winter. Increased body size is also associated with higher reproductive output. Additionally, when countergradient variation acts on developmental rates, embryos that develop sooner or hatch out larger will have more time to grow or require less resources, respectively.
Since these inherently fast growth rates are not observed in all populations, it seems there are potential trade-offs that would prevent this from being beneficial in low latitude populations. One proposed detriment of enhanced embryonic growth is that animals use too much of their supplied nutrients or yolk during development. In some species of lizards the yolk remaining after hatching is absorbed into the body and used as energy for growth as a hatchling. The use of more yolk energy during development diminishes the reserves available for hatchling growth and can impact hatchling survival. Another hypothesis is that animals that grow quickly do not expend as much energy on differentiation or cellular maintenance because they have shorter incubation times. This allows more energy to be used for growth, but less energy for differentiation. Increased growth has been shown to lead to higher occurrences of defects or complications that cause higher rates of mortality. Some examples include rapid growth leading to bone deformities in sandhill cranes and increased risk of cardiovascular problems in Atlantic salmon.Animals are able to employ different strategies for growth and development to counteract environmental challenges. However, the fact that all individuals do not grow faster and the presence of the mentioned potential fitness trade-offs show that there must be some limit to how much animals can use countergradient growth to compensate for environmental conditions that cause slow growth. Studies of countergradient variation are being explored as a useful way to predict the evolutionary constraints animals face in differing environmental conditions.

== Notes ==


The Cytodeme is the total assembly of organisms that use an identical suite of chromosomes to carry their genes. The term was first printed in the 1950s in a book by Heslop-Harrison. Discussing the Deme Terminology - he continued "cytodeme, a population differing in some distinctive cytological feature from others." In most cases the suite is composed of several pairs of homologous chromosomes with or without a pair of sex chromosomes. Since the only acceptable proof of the identity (homology) of chromosomes lies in their ability to pair fully from end to end during meiosis it follows that:

In asexual taxa membership of a cytodeme can only be presumed on such evidence as visual similarity of chromosomal ideotype, but never proved.
In sexual taxa all of the members of one cytodeme are fully intercompatible (within the limits of sex and other genetical constraints like self-incompatibility mechanisms) yielding the fertile progeny which proves their membership.As a general rule for most species all of its members are of the same cytodeme excepting only the infrequent aneuploid aberrants. However some species are known to include several chromosome races which must necessarily belong to different cytodemes. Although it is not intrinsic in the formal definition it is a matter of common observation that members of different cytodemes are essentially cross-incompatible and any hybrids that do arise are usually highly infertile.

Significance
The current surge of interest in cytodemes stems from the realisation that membership of the cytodeme is not necessarily restricted to the members of one species: frequently two or more species are in fact of the same cytodeme. Although fully intercompatible and yielding fertile hybrids when they do cross these species never or rarely cross-breed in the natural environment because they are spatially isolated, geographically and/or ecologically. Typically the species involved are members of the same genus. There are now a substantial number of cases in which two or more species of the same cytodeme are clearly different and even in different genera. Thus all five diploid species recognised in the genus Brassicella and both species recognised in the genus Hutera (7spp. in total) are in the same cytodeme. Perhaps the most extreme case on record concerns the wild grass, teosinte, Euchlaena mexicana and the strikingly different Maize, or Indian Corn, Zea mays, both 2n=20, fully interfertile and yielding fertile hybrids. There is perhaps a remote possibility that two such very different species could have evolved independently from distinct sources and converged in their chromosomal ideotype until they became members of the same cytodeme (including the capacity to cross-breed). It is more likely, though, that the cytodeme arose first complete with its suite of chromosomes and breeding patterns all intact and then, remaining constant in its fundamentals, it diversified into species sometimes so different as to merit generic distinction. Thus, in what may be termed the cytodeme adjunct to Darwinian theory, evolution becomes a two-stage process - first, the establishment of distinct cytodemes reproductively isolated both from one another and from all previously existing cytodemes; second, diversification within cytodeme to yield taxonomically recognisable (but not reproductively isolated) species.
Whereas the second stage is Natural Selection as expounded by Darwin, the first stage is not necessarily Darwinian. In the special case of polyploidy it is known that the first stage is not Darwinian. Doubling the chromosome number of the sterile hybrid between two diploid cytodemes yields an allotetraploid which is both fertile within its bounds and essentially incompatible with all previous life forms.
As yet no mechanism is known which could account for the origin of new diploid cytodemes - nor is there any proof that there are any diploid cytodemes of recent origin. Indeed, the evidence is that cytodemes are remarkably long lived. Presumably the Platanus cytodeme existed on Pangaea before that land fragmented. The present day forms of Platanus - P. orientalis in Europe and P. occidentalis in America - are fully intercompatible when brought together artificially in Botanic Gardens yielding fertile hybrids like the London plane, establishing not only that they are in the same cytodeme as one another but also that they are both in the same cytodeme as their common ancestor of approximately 200 million years ago.

References
Further reading
Lannér, Carita. "Genetic relationships within the Brassica oleracea cytodeme: comparison of molecular marker systems." Acta Universitatis Agriculturae Sueciae. Agraria (Sweden) (1997).
LIU, Yao, and Wei QIAN. "Crossability among Variant Types of Brassica oleracea Cytodeme." Journal of Plant Genetic Resources 14.2 (2013): 342-346.
Warwick, S.I.; Black, L.D. (1991). "Molecular systematics of Brassica and allied genera (Subtribe Brassicinae, Brassiceae) ?chloroplast genome and cytodeme congruence". Theoretical and Applied Genetics. 82 (1): 81–92. doi:10.1007/BF00231281. ISSN 0040-5752. PMID 24212864. S2CID 10758800.
Gómez-Campo, César, ed. Biology of Brassica coenospecies. Vol. 4. Elsevier, 1999.
Kowalski, Stanley P., et al. "Comparative mapping of Arabidopsis thaliana and Brassica oleracea chromosomes reveals islands of conserved organization."Genetics 138.2 (1994): 499-510.
Mei, J., et al. "Genetic investigation of the origination of allopolyploid with virtually synthesized lines: application to the C subgenome of Brassica napus."Heredity 106.6 (2011): 955-961.


Cytotaxonomy is the classification of organisms using comparative studies of chromosomes during mitosis.

Description
Cytotaxonomy is a branch of taxonomy that uses the characteristics of cellular structures to classify organisms. In cytotaxonomy, the chromosomal configuration of an organism is the most widely used parameter to infer the relationship between two organisms. The inference of species relationships is based on the assumption that closely related species share similar characteristics in their chromosomal setup (referred to as karyotype). By analysing the similarities and differences in the chromosomes, karyotype evolution and species evolution can be reconstructed.
The number, structure, and behaviour of chromosomes is of great value in taxonomy, with chromosome number being the most widely used and quoted character. Chromosome numbers are usually determined at the metaphase stage during mitosis. Usually, the diploid chromosome number (2n) is referenced, unless dealing with a polyploid series in which case the base number or number of chromosomes in the genome of the original haploid is quoted. Another useful taxonomic character is the position of the centromere. Meiotic behaviour may show the heterozygosity of inversions. This may be constant for a taxon, offering further taxonomic evidence.
Often, cytological evidence is accompanied and strengthened by other analyses, including genomics and DNA-based phylogenies.
Cytology has contributed to tracking the evolutionary history of many organisms, especially primates and flowering plants. As example, karyotype comparisons have largely clarified the evolution of Arabidopsis thaliana and of saffron crocus, though there are many more studies that deserve highlighting.

== References ==


In biology, a deme, in the strict sense, is a group of individuals that belong to the same taxonomic group. However, when biologists, and especially ecologists, use the term ‘deme’ they usually refer to it as the definition of a gamodeme: a local group of individuals (from the same taxon) that interbreed with each other and share a gene pool. The latter definition of a deme is only applicable to sexual reproducing species, while the former is more neutral and also takes asexual reproducing species into account, such as certain plant species. In the following sections the latter (and most frequently used) definition of a deme will be used.
In evolutionary computation, a "deme" often refers to any isolated subpopulation subjected to selection as a unit rather than as individuals.

Local adaptation
A population of a species usually has multiple demes. Environments between these demes can differ. Demes could, therefore, become locally adapted to their environment. A good example of this is the Adaptive Deme Formation (ADF) hypothesis in insects. The ADF hypothesis states that herbivorous insects can become adapted to specific host plants in their local environment because local plants can have unique nutrient patches to which insects may become adapted. This hypothesis predicts that less mobile insect demes are more likely to become locally adapted than more dispersive insect. However, a meta-analysis, based on 17 studies on this subject, showed that dispersive insect demes were as likely to become locally adapted as less mobile insects. Moreover, this study found a small indication that feeding behaviour might stimulate the local adaptation of demes. Endophagous insects were more likely to become locally adapted than exophagous insects. The explanation for this could be that endophagous insects come in more close and continuous contact to the plant's mechanical, chemical and phenological defensive mechanisms.

Speciation and demes
Speciation could occur at the level of demes. When a deme gets geographically isolated from other demes of the same species, gene-flow between these demes will stop which could lead to speciation after a long time. This is called allopatric speciation and is generally a slow process.On the contrary, sympatric speciation can be more rapid when a species has multiple small demes. This rapid speciation is both observed in plants and vertebrates. Rapid speciation is explained by the ecology and social structure of demes. Species that behave more territorial, live in patchy environments and/or have a polygynous breeding system with only one reproductive male tend to have smaller deme sizes. Interbreeding between small demes is rare due to these factors. Furthermore, alleles fixate more rapidly in smaller demes. Small demes could, therefore, become genetically distinct from each other.Primates, for example, have the second highest speciation rate among mammals, with one speciation event per lineage every 3 million years. However, not all primate species have a high speciation rate; this is reflected in their deme size and social structure. Guenons (Cercopithecus), for example, live together in small polygynous troops and are a quite diverse genus. On the other hand, baboons (Papio) have a much lower speciation rate. Baboons have larger deme sizes because they live in polygynous multi-male troops. These baboon demes are usually allopatric but gene-flow still exists between demes with hybridization being common.

Examples
Various populations of gorillas can be understood by their geographical separation and have been assessed to determine distinct and disjointed gene pools. The polar bear, Ursus maritimus, is understood to have 19 identifiable demes, even though their circumpolar distribution allows some interchange among the demes.

See also
Fragmented habitat
Population genetics
Memetics

== References ==


Dermatoglyphics (from Ancient Greek derma, "skin", and glyph, "carving") is the scientific study of fingerprints, lines, mounts and shapes of hands, as distinct from the superficially similar pseudoscience of palmistry.
Dermatoglyphics also refers to the making of naturally occurring ridges on certain body parts, namely palms, fingers, soles, and toes. These are areas where hair usually does not grow, and these ridges allow for increased leverage when picking up objects or walking barefoot.
In a 2009 report, the scientific basis underlying dermatoglyphics was questioned by the National Academy of Sciences, for the discipline's reliance on subjective comparisons instead of conclusions drawn from the scientific method.

History
1823 marks the beginning of the scientific study of papillary ridges of the hands and feet, with the work of Jan Evangelista Purkyně.By 1858, Sir William Herschel, 2nd Baronet, while in India, became the first European to realize the value of fingerprints for identification.
Sir Francis Galton conducted extensive research on the importance of skin-ridge patterns, demonstrating their permanence and advancing the science of fingerprint identification with his 1892 book Fingerprints.
In 1893, Sir Edward Henry published the book The classification and uses of fingerprints, which marked the beginning of the modern era of fingerprint identification and is the basis for other classification systems.
In 1929, Harold Cummins and Charles Midlo M.D., together with others, published the influential book Fingerprints, Palms and Soles, a bible in the field of dermatoglyphics.
In 1945, Lionel Penrose, inspired by the works of Cummins and Midlo, conducted his own dermatoglyphic investigations as a part of his research into Down syndrome and other congenital medical disorders.
In 1976, Schaumann and Alter published the book Dermatoglyphics in Medical Disorders, which summarizes the findings of dermatoglyphic patterns under disease conditions.
In 1982, Seltzer, et al., conducted a study on patients with breast cancer, and concluded that the presence of six or more whorls on a woman's fingertips indicated her being at high risk for breast cancer.
Although the study of dermatoglyphics has some adjunctive value in the diagnosis of genetic syndromes (see examples below), there is insufficient evidence to indicate that there is any value in the examination of dermal ridge patterns for the diagnosis of disease or for identifying disease susceptibility.

Dermatoglyphics and genetic conditions
Dermatoglyphics, when correlated with genetic abnormalities, aids in the diagnosis of congenital malformations at birth or soon after.

Klinefelter syndrome: excess of arches on digit 1, more frequent ulnar loops on digit 2, overall fewer whorls, lower ridge counts for loops and whorls as compared with controls, and significant reduction of the total finger ridge count.
Cri du chat (5p-): abnormal dermatoglyphics, including single transverse palmar creases and triradii in the t' position on both hands, are associated with 92% of patients, according to a critical review of multiple studies.
Congenital blindness: Initial data points to abnormal triradius.
Naegeli–Franceschetti–Jadassohn syndrome: patients lack dermatoglyphics of any kind.
Noonan syndrome: increased frequency of whorls on fingertips; and the axial triradius t, as in Turner syndrome, is more often in position t' or t" than in controls. Increased incidence of the single transverse palmar crease.
Trisomy 13 (Patau syndrome): excess of arches on fingertips and single transverse palmar creases in 60% of patients. Additionally, the hallucal fibular arches tend to form "S" patterns.
Trisomy 18 (Edward's syndrome): 6–10 arches on fingertips and single transverse palmar creases in 30% of patients.
Trisomy 21 (Down syndrome): people with Down syndrome have a fingerprint pattern with mainly ulnar loops, and a distinct angle between the triradia a, t, and d (the 'adt angle'). Other differences include a single transverse palmar crease ("Simian line") (in 50% of patients), patterns in the hypothenar and interdigital areas, and lower ridge counts along digital midlines, especially in little fingers, which corresponds to finger shortening in those with Down syndrome. There is less variation in dermatoglyphic patterns between people with Down syndrome than between controls, and dermatoglyphic patterns can be used to determine correlations with congenital heart defects in individuals with Down syndrome by examining the left hand digit ridge count minus the right hand digit ridge count, and the number of ridges on the fifth digit of the left hand.
Turner syndrome: predominance of whorls, though the pattern frequency depends on the particular chromosomal abnormality.
Rubinstein-Taybi Syndrome: preponderance of broad thumbs, low mean ridge count, and fingerprint patterns occurring on interdigital areas.
Schizophrenia: A-B ridge counts are generally lower than in controls.
Tel Hashomer camptodactyly syndrome : Dermatoglyphic characters that need to be present to diagnose THC are: (a) presence of seven or more whorls on digits (these whorls extend beyond the borders of the terminal phalanges), (b) low main line index, caused by the highly vertical orientation of the A to D radiants, and (c) numerous palmar creases that obliterate the normal structure of the ridges and openings of the sweat pores.

Dermatoglyphics and Medical conditions
The relationship between different dermatoglyphic traits and various medical diseases have been widely evaluated.

Hypertension: A systematic review shows some evidence suggesting that hypertensive patients tend to have an elevated frequency of digital whorl patterns that goes along with having higher average ridge counts than controls.

References

== Further reading ==


Distyly is a type of heterostyly in which a plant demonstrates reciprocal herkogamy. This breeding system is characterized by two separate flower morphs, where individual plants produce flowers that either have long styles and short stamens (L-morph flowers), or that have short styles and long stamens (S-morph flowers).  However, distyly can refer to any plant that shows some degree of self-incompatibility and has two morphs if at least one of the following characteristics is true; there is a difference in style length, filament length, pollen size or shape, or the surface of the stigma. Specifically these plants exhibit intra-morph self-incompatibility, flowers of the same style morph are incompatible. Distylous species that do not exhibit true self-incompatibility generally show a bias towards inter-morph crosses - meaning they exhibit higher success rates when reproducing with an individual of the opposite morph.

Background
The first scientific account of distyly can be found in Stephan Bejthe's Caroli book Clusii Atrebatis Rariorum aliquot stirpium .  Bejthe describes the two floral morphs of Primula veris. Charles Darwin popularized distyly with his account of it in his book The Different Forms of Flowers on Plants of the Same Species. Darwin's book represents the first account of intramorphic self-incompatibility in distylous plants and focuses on garden experiments in which he looks at seed set of different distylous Primula. Darwin names the two floral morphs S- and L-morph, moving away from the vernacular names, Pin (for L-morph) and Thrum (for S-morph), which he states were initially assigned by florist.
Distylous species have been identified in 28 families of Angiosperm, likely evolving independently in each family. This means, the system has evolved at least 28 times, though it has been suggested the system has evolved multiple times within some families. Since distyly has evolved more than once, it is considered a case of convergent evolution.

Reciprocal herkogamy
Reciprocal herkogamy likely evolved to prevent the pollen of the same flower from landing on its own stigma. This in turn promotes outcrossing.
In a study of Primula veris it was found that pin flowers exhibit higher rates of self-pollination and capture more pollen than the thrum morph. Different pollinators show varying levels of success while pollinating the different Primula morphs, the head or proboscis length of a pollinator is positively correlated to the uptake of pollen from long styled flowers and negatively correlated for pollen uptake on short styled flowers. The opposite is true for pollinators with smaller heads, such as bees, they uptake more pollen from short styled morphs than long styled ones. The differentiation in pollinators allows the plants to reduce levels of intra-morph pollination.

Models of evolution
There are two main hypothetical models for the order in which the traits of distyly evolved, the 'selfing avoidance model'  and the 'pollen transfer model'.
The selfing avoidance model suggests self-incompatibility (SI) evolved first, followed by the morphological difference. It was suggested that the male component of SI would evolve first via a recessive mutation, followed by female characteristics via a dominant mutation, and finally male morphological differences would evolve via a third mutation.
The pollen transfer model argues that morphological differences evolved first, and if a species is facing inbreeding depression, it may evolve SI. This model can be used to explain the presence of reciprocal herkogamy in self-compatible species.

Genetic control of distyly
A supergene, called the self-incompatibility (or S-) locus, is responsible for the occurrence of distyly. The S-locus is composed of three tightly linked genes (S-genes) which segregate as a single unit.Traditionally it was hypothesized that one S-gene controls all female aspects of distyly, one gene that controls the male morphological aspects, and one gene that determines the male mating type. While this hypothesis appears to be true in Turnera, it is not true in  Primula  nor Linum.  The S-morph is hemizygous for the S-locus and the L-morph does not have an allelic counterpart . The hemizygotic nature of the S-locus has been shown in Primula  , Gelsemium, Linum , Fagopyrum , Turnera, and Nymphoides.The presence of the S-locus results in changes to gene expression between the two floral morphs, as has been demonstrated using transcriptomic analyses of Lithospermum multiflorum  , Primula veris, Primula oreodoxa , Primula vulgaris  and Turnera subulata.

The S-locus of Fagopyrum
The S-morph of Fagopyrum contains ~2.8 Mb hemizygous region which likely represents the S-locus as it contains S-ELF4 which establishes female morphology and mating type.

The S-locus of Gelsemium
In Gelsemium, the S-locus is composed of four genes, GeCYP, GeFRS6, and GeGA3OX are hemizygous and TAF2 appears to be allelic with a truncated copy in the L-morph. GeCYP appears to share a last common ancestor (or ortholog) with the Primula S-gene CYPT.  It is currently hypothesized that the for S-genes in Gelsemium were inherited as a group rather than separately. This is the only known case of the S-genes being inherited as a group rather than individually.

The S-locus of Linum
In Linum the S-locus is composed of nine genes, two are LtTSS1 and LtWDR-44 the other seven are unnamed and are of unknown function. LtTSS1 is hypothesized to regulate style length in the S-morph. Synonymous substitution analysis of three of the S-genes suggest the S-locus in Linum evolved in a step by step manner, though only three of the nine genes were analyzed.

The S-locus of Nymphoides
The S-locus of Nymphoides contains three genes NinS1, NinKHZ2, and NinBAS1. NinBAS1 is only expressed in the style and is hypothetical involved in regulation of brassinosteroids, NinS1 is only expressed in the stamen, NinKHZ2 is expressed in both stamen and style. Similar to other S-loci, the Nymphoides S-locus appears to have evolved via stepwise duplication events.

The S-locus of Primula
In Primula the S-locus is composed of five genes, CYPT(or CYP734A50), GLOT (or GLOBOSA2), KFBT, PUMT, and CCMT. The supergene evolved in a step-by-step manner, meaning each S-gene duplicated and move to the pre-S-locus independently of the others. Synonymous substitution analysis of the S-genes suggest the oldest S-gene in Primula is likely KFBT which likely duplicated about 104 million years ago, followed by CYPT(42.7 MYA),GLOT (37.4 MYA), CCMT(10.3 MYA). It is unknown when PUMT evolved as it does not have a paralog within the Primula genome.
Of the five S-genes, two have been characterized. CYPT, a cytochrome P450 family member, is the female morphology and it is the female self-incompatibility gene, meaning it promotes rejection of self pollen. CYPT  is likely producing these phenotypes via inactivation of brassinosteroids. Inactivation of brassinosteroids in the S-morph by CYPT results in repression of cell elongation in the style by repressing expression of PIN5, ultimately producing the short pistil phenotype.  GLOT , a MADS-BOX family member, is the male morphology gene as it promotes corolla tube growth under the stamen. It is unknown how the other three S-genes are contributing to distyly in Primula.

The S-locus of Turnera
In Turnera the S-locus is composed of three genes, BAHD, SPH1, and YUC6. BAHD is likely an acyltransferase involved in inactivation of brassinosteroids; it is both the female morphology and female self-incompatibility gene. YUC6 is likely involved in auxin biosynthesis based on homology; it is the male self-incompatibility gene and establishes pollen size dimorphisms. SPH1 is likely involved in filament elongation based on short filament mutant analysis.

List of families with distylous species
Source:

== References ==


A diversity panel is a collection of genetic material or individual samples taken from a diverse population of a certain species. The idea is to illustrate the genetic and phenotypic diversity of the species.
Diversity panels exist for human populations, mouse and other organisms.
Researchers in the area of genetics often use diversity panels in order to reveal genotypes that are linked to certain traits, such as in QTL mapping with Genome-wide association study.
Those study analyze the Gene–environment interaction underneath simple and complex traits.

Examples
Human Genome Diversity Project
The Hybrid Mouse Diversity Panel
Maize NAM population (Nested association mapping)
Arabidopsis thaliana 1001 Genome project

See also
Genetics
Biodiversity
Evolution

== References ==


In psychology, a trait (or phenotype) is called emergenic if it is the result of a specific combination of several interacting genes (rather than of a simple sum of several independent genes). Emergenic traits will not run in families, but identical twins will share them. Traits such as "leadership", "genius" or certain mental illnesses may be emergenic.
Although one may expect epigenetics to play a significant role in the phenotypic manifestation of twins reared apart, the concordance displayed between them can be attributed to emergenesis.

== References ==